OncLive | Bringing the Global Oncology Community Together

Patients with newly diagnosed or relapsed/refractory chronic lymphocytic leukemia achieved objective response rates as high as 100% with either of 2 doses of the BTK inhibitor acalabrutinib, results of an open-label... Read More >>

Paradigm Evolving in HER2+ Breast Cancer With CNS Mets

BiTE Antibodies Show Encouraging Activity in Myeloma, AML

Expert Highlights TAS-102 Potential in Gastric/GEJ Cancer

CDK4/6 Inhibitors Are Transforming Treatment in HR+ Breast Cancer

Selinexor Promotes Deep, Durable Responses in Relapsed/Refractory DLBCL

View More Stories >>

View Conference Coverage

2018 San Antonio Breast Cancer Symposium

2018 ASH Annual Meeting

2018 Ruesch Center Symposium

2018 Chemotherapy Foundation Symposium

2018 New York Lung Cancers Symposium

Dr. Esteva on the Trastuzumab Biosimilar Candidate CT-P6 in HER2+ Breast Cancer

Dr. Geyer on the Rationale for the KATHERINE Trial in HER2-Positive Breast Cancer

Dr. O'Regan on Future of Chemotherapy in Breast Cancer

Dr. Patel on Induction Therapy With Bendamustine and Rituximab in MCL

Dr. Madduri on Treatment After CAR T Cells in Myeloma

Dr. Vaena on the Importance of Risk Stratification in Prostate Cancer

OncLive houses thousands of videos that provide updates and information.
See more Videos

Surgery Options for NSCLC & I-O Therapy in EGFR-Mutations

I-O Options for Stage III NSCLC & International PD-L1 Restrictions

PACIFIC Trial: Positive New Data in OS & PFS

Second-Line after I-O: Where Do We Go from There?

Adjuvant Therapy in Melanoma: COMBI-AD Trial

Molecular Testing for Stage III Melanoma

OncLive houses thousands of videos that provide updates and information.
See more Videos

Diagnosis and Staging of Advanced/Metastatic CSCC

Incidence and Prevalence of Advanced/Metastatic CSCC

Other Clinical Trials in Renal Cell Carcinoma

A Novel Approach: TKI/I-O Combinations in RCC

The Logistics of Building a CAR-T Program

OncLive houses thousands of videos that provide updates and information.
See more Videos

Featured

Expert Anticipates Cure in Acute Lymphoblastic Leukemia

Elias Jabbour, MD, discussed recent clinical trial results in acute lymphoblastic leukemia, the role of immunotherapy, and the biggest challenges facing the field.

View more >>>

Featured

Dr. Ramchandren on the North American Results of the ECHELON-1 Study in Hodgkin Lymphoma

Radhakrishnan Ramchandren MD, associate professor, Wayne State University School of Medicine, Barbara Ann Karmanos Cancer Institute, discusses the North American results of the ECHELON-1 study in Hodgkin lymphoma.

View more >>>